Kestra Medical Technologies Ltd. shares fell 8.6% to $21.99 in premarket trading after the company reported a first-quarter loss of 75 cents per share, wider than the analyst consensus estimate of 62 cents. Quarterly sales reached $30.971 million, exceeding the $29.007 million consensus forecast. Enova International led other decliners after withdrawing applications related to its proposed Grasshopper Bancorp acquisition, while Contineum Therapeutics fell after its MOONLIGHT-1 trial missed its primary efficacy endpoint. Several stocks that gained on Monday, including Circle Internet Group, RELX, Twenty One Capital, Bullish and Coinbase Global, also moved lower before the market opened.